Cargando…

CCR5 as a Natural and Modulated Target for Inhibition of HIV

Human immunodeficiency virus type 1 (HIV-1) infection of target cells requires CD4 and a co-receptor, predominantly the chemokine receptor CCR5. CCR5-delta32 homozygosity results in a truncated protein providing natural protection against HIV infection—this without detrimental effects to the host—an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Burke, Bryan P., Boyd, Maureen P., Impey, Helen, Breton, Louis R., Bartlett, Jeffrey S., Symonds, Geoff P., Hütter, Gero
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3917431/ https://www.ncbi.nlm.nih.gov/pubmed/24381033 http://dx.doi.org/10.3390/v6010054

Ejemplares similares

CCR5 Targeted Cell Therapy for HIV and Prevention of Viral Escape
por: Hütter, Gero, et al.
Publicado: (2015)

Preclinical safety and efficacy of an anti–HIV-1 lentiviral vector containing a short hairpin RNA to CCR5 and the C46 fusion inhibitor
por: Wolstein, Orit, et al.
Publicado: (2014)

Clearing the HIV reservoir by transplanting CCR5 deficient stem cells
por: Hütter, Gero
Publicado: (2011)

Eradication of HIV by Transplantation of CCR5-Deficient Hematopoietic Stem Cells
por: Hütter, Gero, et al.
Publicado: (2011)

Coregulation of HIV-1 dependency factors in individuals heterozygous to the CCR5-delta32 deletion
por: Hütter, Gero, et al.
Publicado: (2013)

Stochastic Model of In-Vivo X4 Emergence during HIV Infection: Implications for the CCR5 Inhibitor Maraviroc
por: Savkovic, Borislav, et al.
Publicado: (2012)

Natural anti-CCR5 antibodies in HIV-infection and -exposure
por: Lopalco, Lucia
Publicado: (2011)

The effect of the CCR5-delta32 deletion on global gene expression considering immune response and inflammation
por: Hütter, Gero, et al.
Publicado: (2011)

Gene therapy to cure HIV? Prospects and realities
por: Hütter, Gero
Publicado: (2012)

Stem cell transplantation in strategies for curing HIV/AIDS
por: Hütter, Gero
Publicado: (2016)

Targeting CCR5 trafficking to inhibit HIV-1 infection
por: Boncompain, Gaelle, et al.
Publicado: (2019)

CCR5AS lncRNA variation differentially regulates CCR5, influencing HIV disease outcome
por: Kulkarni, Smita, et al.
Publicado: (2019)

CCR5: From Natural Resistance to a New Anti-HIV Strategy
por: Lopalco, Lucia
Publicado: (2010)

Multilineage polyclonal engraftment of Cal-1 gene-modified cells and in vivo selection after SHIV infection in a nonhuman primate model of AIDS
por: Peterson, Christopher W., et al.
Publicado: (2016)

New approaches in the treatment of HIV/AIDS – focus on maraviroc and other CCR5 antagonists
por: Schlecht, Hans P, et al.
Publicado: (2008)

Increasing the efficacy of radiotherapy by modulating the CCR2/CCR5 chemokine axes
por: Connolly, Kelli A., et al.
Publicado: (2016)

CCR5 Inhibition Prevents Cardiac Dysfunction in the SIV/Macaque Model of HIV
por: Kelly, Kathleen M., et al.
Publicado: (2014)

Two HIV-1 Variants Resistant to Small Molecule CCR5 Inhibitors Differ in How They Use CCR5 for Entry
por: Berro, Reem, et al.
Publicado: (2009)

The Geographic Spread of the CCR5 Δ32 HIV-Resistance Allele
por: Novembre, John, et al.
Publicado: (2005)

Blockade of chemokine-induced signalling inhibits CCR5-dependent HIV infection in vitro without blocking gp120/CCR5 interaction
por: Grainger, David J, et al.
Publicado: (2005)

Endocytosis and Recycling of the HIV Coreceptor Ccr5
por: Signoret, Nathalie, et al.
Publicado: (2000)

CCR5 Inhibitors and HIV-1 Infection
por: Latinovic, Olga S., et al.
Publicado: (2019)

Transplantation of selected or transgenic blood stem cells – a future treatment for HIV/AIDS?
por: Hütter, Gero, et al.
Publicado: (2009)

Plans des locaux : MCR et CCR (CCR = Cable Connecting Room)
por: Collet, P, et al.
Publicado: (1971)

Plans des locaux : MCR et CCR (CCR = Cable Connecting Room)
por: Collet, P, et al.
Publicado: (1971)

Modulation of inflammatory pain in response to a CCR2/CCR5 antagonist in rodent model
por: Okamoto, Masayuki, et al.
Publicado: (2013)

Natural Proteolytic Processing of Hemofiltrate Cc Chemokine 1 Generates a Potent Cc Chemokine Receptor (Ccr)1 and Ccr5 Agonist with Anti-HIV Properties
por: Detheux, Michel, et al.
Publicado: (2000)

Macrocyclic polyamines inhibit HIV infection by interacting with the cellular HIV co-receptors CXCR4 and CCR5
por: Schols, Dominique, et al.
Publicado: (2009)

Anti-phospholipid human monoclonal antibodies inhibit CCR5-tropic HIV-1 and induce β-chemokines
por: Moody, M. Anthony, et al.
Publicado: (2010)

Class B β-arrestin2-dependent CCR5 signalosome retention with natural antibodies to CCR5
por: Venuti, Assunta, et al.
Publicado: (2016)

The Abrogation of Phosphorylation Plays a Relevant Role in the CCR5 Signalosome Formation with Natural Antibodies to CCR5
por: Venuti, Assunta, et al.
Publicado: (2017)

Promoter Targeting shRNA Suppresses HIV-1 Infection In vivo Through Transcriptional Gene Silencing
por: Suzuki, Kazuo, et al.
Publicado: (2013)

People with HIV have higher percentages of circulating CCR5+ CD8+ T cells and lower percentages of CCR5+ regulatory T cells
por: van Eekeren, Louise E., et al.
Publicado: (2022)

Clinical use of CCR5 inhibitors in HIV and beyond
por: Gilliam, Bruce L, et al.
Publicado: (2011)

The role of CCR5 in HIV-associated neurocognitive disorders
por: Riviere-Cazaux, Cecile, et al.
Publicado: (2022)

Beyond HIV infection: Neglected and varied impacts of CCR5 and CCR5Δ32 on viral diseases
por: Ellwanger, Joel Henrique, et al.
Publicado: (2020)

Development of a CCR5-tropic HIV-1 fusion inhibition assay amenable to high-throughput screening for topical microbicides
por: Beer, B, et al.
Publicado: (2006)

The enzyme activities of Caf1 and Ccr4 are both required for deadenylation by the human Ccr4–Not nuclease module
por: Maryati, Maryati, et al.
Publicado: (2015)

Architecture of the Ubiquitylation Module of the Yeast Ccr4-Not Complex
por: Bhaskar, Varun, et al.
Publicado: (2015)

Phase I/II Clinical Trials Using Gene-Modified Adult Hematopoietic Stem Cells for HIV: Lessons Learnt
por: Mitsuyasu, Ronald T., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_h3r8g2opbh94hlnmtapqrn1j5j